Anacor Pharmaceuticals, Inc. (ANAC) Misses Q1 EPS by 5c

Article Stock Quotes (1) Comments (0)

Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) reported Q1 EPS of ($0.48), $0.05 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $2.42 million versus the consensus estimate of $3.65 million.

For earnings history and earnings-related data on Anacor Pharmaceuticals, Inc. (ANAC) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
• Infoblox (BLOX) Tops Q3 EPS by 5c; Issues Outlook
• Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?